Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-04-031045
Filing Date
2004-10-13
Accepted
2004-10-13 16:06:33
Documents
3
Effectiveness Date
2004-10-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2144825zdefa14a.htm DEFA14A 11385
2 G47845.JPG g47845.jpg GRAPHIC 4940
3 G507738.JPG g507738.jpg GRAPHIC 1543
  Complete submission text file 0001047469-04-031045.txt   19666
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: DEFA14A | Act: 34 | File No.: 001-12493 | Film No.: 041077148
SIC: 2836 Biological Products, (No Diagnostic Substances)